Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by ANDREW FUTREAL and VAN KARLYLE MORRIS.
ANDREW FUTREAL
Connection Strength
0.055
VAN KARLYLE MORRIS
  1. Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC). J Immunother Cancer. 2022 08; 10(8).
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.